Characterization of an Amphetamine Interference from Gabapentin in an LC-HRMS Method.

Muñoz-Muñoz, Ana Celia; Pekol, Teresa; Schubring, Dana; Hyland, Robin; Johnson, Charlene; Andrade, Lawrence

Muñoz-Muñoz, Ana Celia; Pekol, Teresa; Schubring, Dana; Hyland, Robin; Johnson, Charlene; Andrade, Lawrence.

Afiliação

Muñoz-Muñoz AC; Research and Development, Dominion Diagnostics LLC, 211 Circuit Drive, North Kingstown, RI 02852, USA.
Pekol T; Research and Development, Dominion Diagnostics LLC, 211 Circuit Drive, North Kingstown, RI 02852, USA.
Schubring D; Research and Development, Dominion Diagnostics LLC, 211 Circuit Drive, North Kingstown, RI 02852, USA.
Hyland R; Research and Development, Dominion Diagnostics LLC, 211 Circuit Drive, North Kingstown, RI 02852, USA.
Johnson C; Research and Development, Dominion Diagnostics LLC, 211 Circuit Drive, North Kingstown, RI 02852, USA.
Andrade L; Research and Development, Dominion Diagnostics LLC, 211 Circuit Drive, North Kingstown, RI 02852, USA.

J Anal Toxicol ; 44(1): 36-40, 2020 Jan 07.

Article em En | MEDLINE | ID: mdl-31263895

Assuntos

Anfetamina/metabolismo; Gabapentina/metabolismo; Anfetamina/química; Cromatografia Líquida de Alta Pressão; Cromatografia Líquida; Gabapentina/química; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gabapentina / Anfetamina Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google